Merck, Johnson & Johnson and Amgen are among the first drugmakers to have products chosen for a contentious initiative to rein in prescription-drug costs.
You are here: Home / Top Stories / : Eliquis, Jardiance among first 10 drugs selected for Medicare price negotiations